NAUTILUS BIOTECHNOLOGY INC (NAUT)
US63909J1088 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -67.43M | -63.67M | -57.92M | -50.32M | -15.62M | |||
| Depreciation Amortization | 1.98M | 1.85M | 1.22M | 1.02M | 710.00K | |||
| Change In Working Capital | -3.79M | -3.22M | -790.00K | -20.00K | -1.39M | |||
| Other non cash items | 13.79M | 13.33M | 11.69M | 10.08M | 2.30M | |||
| OPERATING CASH FLOW | -55.46M | -51.71M | -45.81M | -39.24M | -14.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.40M | -2.44M | -2.32M | -2.27M | -920.00K | |||
| Other Investing Activity | -5.49M | -41.29M | -23.42M | -136.70M | -24.36M | |||
| INVESTING CASH FLOW | -7.88M | -43.73M | -25.74M | -138.96M | -25.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | -60.00K | |||
| Stock Issued/Repurchased | 613.00K | 368.00K | 560.00K | 170.00K | 40.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | 327.28M | 75.86M | |||
| FINANCING CASH FLOW | 613.00K | 368.00K | 560.00K | 327.45M | 75.90M | |||
| CHANGE IN CASH | -62.73M | -95.08M | -70.99M | 149.25M | 36.62M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -55.46M | -51.71M | -45.81M | -39.24M | -14.00M | |||
| Capital Expenditure | -2.40M | -2.44M | -2.32M | -2.27M | -920.00K | |||
| FREE CASH FLOW | -57.86M | -54.15M | -48.13M | -41.51M | -14.92M | |||
All data in USD